By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical said on Wednesday that full-year 2011 revenues rose 32 percent year over year, driven by growth in product sales.

Full-year revenues for the firm came in at C$9.5 million (US$9.5 million), up from C$7.1 million a year ago, as product sales also increased 32 percent year over year to C$9.0 million from C$6.8 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.